| 0 |
HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA REFRACTORY |
4 |
0.8000 |
| 1 |
HERPETIC RADICULOPATHY |
1 |
0.1250 |
| 2 |
PRIMARY CARDIAC LYMPHOMA |
2 |
0.1250 |
| 3 |
BLOOD TYPE INCOMPATIBILITY |
1 |
0.1250 |
| 4 |
HEPATOBILIARY NEOPLASM |
1 |
0.1000 |
| 5 |
EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE IV |
1 |
0.0833 |
| 6 |
TUMOUR FLARE |
56 |
0.0820 |
| 7 |
CD19 ANTIGEN LOSS |
1 |
0.0625 |
| 8 |
INTERSTITIAL LUNG THICKENING |
1 |
0.0625 |
| 9 |
FACTOR XI DEFICIENCY |
1 |
0.0500 |
| 10 |
T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA |
1 |
0.0500 |
| 11 |
CD19 LYMPHOCYTE COUNT ABNORMAL |
1 |
0.0476 |
| 12 |
DIAPHRAGM NEOPLASM |
1 |
0.0435 |
| 13 |
METASTASES TO MOUTH |
1 |
0.0435 |
| 14 |
CYTOKINE RELEASE SYNDROME |
855 |
0.0426 |
| 15 |
RESPIRATORY TRACT NEOPLASM |
1 |
0.0417 |
| 16 |
COR PULMONALE CHRONIC |
7 |
0.0372 |
| 17 |
SIMPLE MASTECTOMY |
1 |
0.0370 |
| 18 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
78 |
0.0353 |
| 19 |
AORTIC PSEUDOANEURYSM |
2 |
0.0339 |
| 20 |
CONGENITAL APLASIA |
9 |
0.0289 |
| 21 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
156 |
0.0263 |
| 22 |
HAIRY CELL LEUKAEMIA RECURRENT |
1 |
0.0244 |
| 23 |
MANTLE CELL LYMPHOMA |
33 |
0.0217 |
| 24 |
BLOOD LACTATE DEHYDROGENASE DECREASED |
7 |
0.0210 |
| 25 |
PERITUMOURAL OEDEMA |
1 |
0.0208 |
| 26 |
BLOOD CATECHOLAMINES DECREASED |
1 |
0.0196 |
| 27 |
COAGULATION FACTOR XIII LEVEL DECREASED |
1 |
0.0192 |
| 28 |
CATHETER SITE PHLEBITIS |
1 |
0.0192 |
| 29 |
NEOPLASM SWELLING |
1 |
0.0185 |
| 30 |
FOLLICULAR LYMPHOMA |
16 |
0.0182 |
| 31 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
17 |
0.0180 |
| 32 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG |
3 |
0.0173 |
| 33 |
MANTLE CELL LYMPHOMA STAGE IV |
1 |
0.0167 |
| 34 |
RENAL HYDROCELE |
1 |
0.0167 |
| 35 |
SUBMANDIBULAR ABSCESS |
1 |
0.0167 |
| 36 |
NECROTIC LYMPHADENOPATHY |
2 |
0.0167 |
| 37 |
URINARY TRACT NEOPLASM |
1 |
0.0161 |
| 38 |
CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE |
3 |
0.0158 |
| 39 |
DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV |
5 |
0.0152 |
| 40 |
LOW DENSITY LIPOPROTEIN |
1 |
0.0147 |
| 41 |
ENCEPHALITIS CYTOMEGALOVIRUS |
6 |
0.0137 |
| 42 |
INFLAMMATORY PSEUDOTUMOUR |
1 |
0.0135 |
| 43 |
IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME |
2 |
0.0132 |
| 44 |
HYPERAMYLASAEMIA |
7 |
0.0128 |
| 45 |
GENITOURINARY TRACT NEOPLASM |
1 |
0.0120 |
| 46 |
ALPHA HYDROXYBUTYRATE DEHYDROGENASE INCREASED |
1 |
0.0116 |
| 47 |
TUMOUR OBSTRUCTION |
1 |
0.0115 |
| 48 |
ACCESSORY SPLEEN |
1 |
0.0111 |
| 49 |
B-CELL LYMPHOMA RECURRENT |
6 |
0.0110 |
| 50 |
LEUKODYSTROPHY |
1 |
0.0108 |
| 51 |
SELECTIVE IGG SUBCLASS DEFICIENCY |
1 |
0.0106 |
| 52 |
PARVOVIRUS INFECTION |
4 |
0.0099 |
| 53 |
URETERAL DISORDER |
4 |
0.0097 |
| 54 |
PARAINFLUENZA VIRUS INFECTION |
1 |
0.0097 |
| 55 |
HYPERPYREXIA |
39 |
0.0092 |
| 56 |
INTERLEUKIN LEVEL INCREASED |
5 |
0.0091 |
| 57 |
ACUTE HEPATITIS B |
3 |
0.0090 |
| 58 |
BLOOD ELECTROLYTES INCREASED |
1 |
0.0085 |
| 59 |
MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL |
1 |
0.0082 |
| 60 |
PLEURAL DISORDER |
5 |
0.0080 |
| 61 |
CD19 LYMPHOCYTES DECREASED |
1 |
0.0077 |
| 62 |
SOFT TISSUE NEOPLASM |
1 |
0.0076 |
| 63 |
LEUKOSTASIS SYNDROME |
1 |
0.0075 |
| 64 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
33 |
0.0075 |
| 65 |
CYTOKINE INCREASED |
1 |
0.0074 |
| 66 |
BRONCHIAL NEOPLASM |
1 |
0.0074 |
| 67 |
CENTRAL NERVOUS SYSTEM VIRAL INFECTION |
1 |
0.0070 |
| 68 |
DIFFUSE LARGE B-CELL LYMPHOMA |
48 |
0.0062 |
| 69 |
MYOCARDIAL INJURY |
7 |
0.0062 |
| 70 |
SYSTEMIC CANDIDA |
15 |
0.0060 |
| 71 |
GIARDIASIS |
2 |
0.0059 |
| 72 |
IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY |
1 |
0.0057 |
| 73 |
JC VIRUS INFECTION |
9 |
0.0056 |
| 74 |
LIMB IMMOBILISATION |
1 |
0.0054 |
| 75 |
ENTEROBACTER SEPSIS |
2 |
0.0054 |
| 76 |
CEREBELLAR ISCHAEMIA |
1 |
0.0054 |
| 77 |
B-LYMPHOCYTE COUNT INCREASED |
1 |
0.0054 |
| 78 |
HAEMATOPOIETIC NEOPLASM |
1 |
0.0053 |
| 79 |
ANISOCORIA |
2 |
0.0053 |
| 80 |
NEUTROPENIC INFECTION |
5 |
0.0052 |
| 81 |
UREAPLASMA INFECTION |
2 |
0.0049 |
| 82 |
CUTANEOUS LYMPHOMA |
1 |
0.0049 |
| 83 |
SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA |
4 |
0.0049 |
| 84 |
CD4 LYMPHOCYTES ABNORMAL |
1 |
0.0048 |
| 85 |
CLOSTRIDIUM BACTERAEMIA |
1 |
0.0047 |
| 86 |
BLOOD IMMUNOGLOBULIN A DECREASED |
3 |
0.0046 |
| 87 |
MANTLE CELL LYMPHOMA RECURRENT |
2 |
0.0046 |
| 88 |
C-REACTIVE PROTEIN DECREASED |
3 |
0.0046 |
| 89 |
CHRONIC GRAFT VERSUS HOST DISEASE |
16 |
0.0044 |
| 90 |
AORTITIS |
3 |
0.0044 |
| 91 |
PLEURAL INFECTION |
1 |
0.0043 |
| 92 |
HYPOGAMMAGLOBULINAEMIA |
28 |
0.0043 |
| 93 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
9 |
0.0042 |
| 94 |
CREST SYNDROME |
1 |
0.0042 |
| 95 |
JEJUNAL PERFORATION |
1 |
0.0041 |
| 96 |
ALANINE AMINOTRANSFERASE DECREASED |
3 |
0.0041 |
| 97 |
TUMOUR INVASION |
2 |
0.0041 |
| 98 |
DISEASE PROGRESSION |
486 |
0.0041 |
| 99 |
DEVICE RELATED THROMBOSIS |
4 |
0.0041 |
| 100 |
INFECTIVE ANEURYSM |
2 |
0.0040 |
| 101 |
CYTOMEGALOVIRUS GASTRITIS |
1 |
0.0040 |
| 102 |
LEUKAEMIC INFILTRATION EXTRAMEDULLARY |
1 |
0.0039 |
| 103 |
INFESTATION |
1 |
0.0039 |
| 104 |
GASTROINTESTINAL LYMPHOMA |
1 |
0.0038 |
| 105 |
HERPES ZOSTER REACTIVATION |
1 |
0.0038 |
| 106 |
CYTOTOXIC OEDEMA |
1 |
0.0038 |
| 107 |
INJECTION RELATED REACTION |
6 |
0.0036 |
| 108 |
URETERIC DILATATION |
1 |
0.0036 |
| 109 |
ENTEROCOLITIS BACTERIAL |
1 |
0.0036 |
| 110 |
DUCTAL ADENOCARCINOMA OF PANCREAS |
1 |
0.0036 |
| 111 |
GENITOURINARY TRACT INFECTION |
1 |
0.0035 |
| 112 |
PSEUDOMONAL BACTERAEMIA |
3 |
0.0035 |
| 113 |
CHOROIDAL NEOVASCULARISATION |
3 |
0.0035 |
| 114 |
HEPATITIS B SURFACE ANTIBODY POSITIVE |
1 |
0.0034 |
| 115 |
TUMOUR LYSIS SYNDROME |
30 |
0.0034 |
| 116 |
CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION |
1 |
0.0034 |
| 117 |
DUODENAL OBSTRUCTION |
1 |
0.0033 |
| 118 |
SUSPECTED OFF LABEL USE |
15 |
0.0033 |
| 119 |
ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT |
1 |
0.0032 |
| 120 |
BILIARY TRACT INFECTION |
2 |
0.0032 |
| 121 |
INTERVERTEBRAL DISCITIS |
6 |
0.0032 |
| 122 |
CHRONIC HEPATITIS B |
1 |
0.0032 |
| 123 |
TUMOUR COMPRESSION |
1 |
0.0031 |
| 124 |
COLORECTAL ADENOMA |
1 |
0.0031 |
| 125 |
TUMOUR PAIN |
4 |
0.0030 |
| 126 |
HYPOFIBRINOGENAEMIA |
3 |
0.0030 |
| 127 |
METASTASES TO BREAST |
1 |
0.0030 |
| 128 |
BLOOD IMMUNOGLOBULIN M DECREASED |
3 |
0.0030 |
| 129 |
SOFT TISSUE INFLAMMATION |
1 |
0.0030 |
| 130 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
4 |
0.0029 |
| 131 |
LYMPHOID TISSUE HYPERPLASIA |
1 |
0.0028 |
| 132 |
LIVER FUNCTION TEST DECREASED |
1 |
0.0028 |
| 133 |
GLOBULINS INCREASED |
1 |
0.0027 |
| 134 |
TUMOUR PSEUDOPROGRESSION |
3 |
0.0027 |
| 135 |
BRONCHOPNEUMOPATHY |
1 |
0.0027 |
| 136 |
CYTOMEGALOVIRUS OESOPHAGITIS |
1 |
0.0027 |
| 137 |
GRANULOCYTE COUNT DECREASED |
5 |
0.0027 |
| 138 |
KLEBSIELLA SEPSIS |
3 |
0.0027 |
| 139 |
HEPATITIS B CORE ANTIBODY POSITIVE |
1 |
0.0027 |
| 140 |
PERIPROSTHETIC FRACTURE |
1 |
0.0026 |
| 141 |
HYPOPROTEINAEMIA |
5 |
0.0026 |
| 142 |
SCLERODERMA RENAL CRISIS |
1 |
0.0026 |
| 143 |
HERPES SIMPLEX REACTIVATION |
1 |
0.0026 |
| 144 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
1 |
0.0026 |
| 145 |
GASTRIC PERFORATION |
7 |
0.0026 |
| 146 |
BLOOD FIBRINOGEN INCREASED |
2 |
0.0025 |
| 147 |
BONE DENSITY INCREASED |
1 |
0.0025 |
| 148 |
VASCULAR ACCESS COMPLICATION |
2 |
0.0025 |
| 149 |
COVID-19 PNEUMONIA |
29 |
0.0025 |
| 150 |
TUMOUR ASSOCIATED FEVER |
1 |
0.0024 |
| 151 |
SQUAMOUS CELL CARCINOMA OF THE TONGUE |
1 |
0.0024 |
| 152 |
POST-ACUTE COVID-19 SYNDROME |
3 |
0.0024 |
| 153 |
GASTROINTESTINAL CANDIDIASIS |
1 |
0.0024 |
| 154 |
B-CELL LYMPHOMA |
8 |
0.0024 |
| 155 |
ABDOMINAL NEOPLASM |
2 |
0.0022 |
| 156 |
ORGANISING PNEUMONIA |
11 |
0.0022 |
| 157 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
3 |
0.0021 |
| 158 |
INTRACRANIAL MASS |
2 |
0.0021 |
| 159 |
PNEUMONIA HAEMOPHILUS |
1 |
0.0021 |
| 160 |
METASTASES TO BONE MARROW |
1 |
0.0020 |
| 161 |
MYELOID LEUKAEMIA |
1 |
0.0020 |
| 162 |
SPLENIC VEIN THROMBOSIS |
1 |
0.0020 |
| 163 |
PO2 INCREASED |
1 |
0.0020 |
| 164 |
PARAINFLUENZAE VIRUS INFECTION |
3 |
0.0020 |
| 165 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
31 |
0.0020 |
| 166 |
CEREBRAL ARTERY THROMBOSIS |
1 |
0.0019 |
| 167 |
GRAFT VERSUS HOST DISEASE |
14 |
0.0019 |
| 168 |
BACTERIAL INFECTION |
36 |
0.0019 |
| 169 |
VARICELLA ZOSTER VIRUS INFECTION |
4 |
0.0019 |
| 170 |
URETEROLITHIASIS |
2 |
0.0019 |
| 171 |
HEPATITIS E |
3 |
0.0019 |
| 172 |
RETROPERITONEAL LYMPHADENOPATHY |
1 |
0.0019 |
| 173 |
RESPIRATORY TRACT INFECTION FUNGAL |
1 |
0.0019 |
| 174 |
CORYNEBACTERIUM INFECTION |
1 |
0.0019 |
| 175 |
BLOOD GASES ABNORMAL |
1 |
0.0019 |
| 176 |
SCROTAL PAIN |
1 |
0.0019 |
| 177 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
7 |
0.0018 |
| 178 |
HEPATORENAL SYNDROME |
3 |
0.0018 |
| 179 |
METASTASES TO MENINGES |
4 |
0.0018 |
| 180 |
VITH NERVE PARALYSIS |
2 |
0.0018 |
| 181 |
BLOOD FIBRINOGEN DECREASED |
2 |
0.0018 |
| 182 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
13 |
0.0017 |
| 183 |
IRREGULAR BREATHING |
1 |
0.0017 |
| 184 |
PROCALCITONIN INCREASED |
2 |
0.0017 |
| 185 |
FEBRILE INFECTION |
2 |
0.0017 |
| 186 |
PNEUMOCYSTIS JIROVECII INFECTION |
2 |
0.0017 |
| 187 |
DIAPHRAGMATIC PARALYSIS |
1 |
0.0017 |
| 188 |
BONE MARROW DISORDER |
5 |
0.0017 |
| 189 |
OXYGEN CONSUMPTION DECREASED |
1 |
0.0017 |
| 190 |
SOFT TISSUE INFECTION |
3 |
0.0016 |
| 191 |
HAEMATOLOGICAL INFECTION |
4 |
0.0016 |
| 192 |
OSTEOMYELITIS CHRONIC |
1 |
0.0016 |
| 193 |
FEBRILE NEUTROPENIA |
107 |
0.0016 |
| 194 |
NECROTISING RETINITIS |
1 |
0.0016 |
| 195 |
AUTOIMMUNE COLITIS |
1 |
0.0016 |
| 196 |
CYTOPENIA |
19 |
0.0016 |
| 197 |
VASCULAR DEVICE INFECTION |
7 |
0.0015 |
| 198 |
PNEUMONIA FUNGAL |
6 |
0.0015 |
| 199 |
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE |
1 |
0.0015 |
| 200 |
ORGAN FAILURE |
6 |
0.0015 |
| 201 |
CYTOKINE STORM |
1 |
0.0015 |
| 202 |
IMMUNOGLOBULINS DECREASED |
2 |
0.0015 |
| 203 |
NEUTROPENIA |
198 |
0.0015 |
| 204 |
CAPILLARY LEAK SYNDROME |
3 |
0.0014 |
| 205 |
HYPERTRANSAMINASAEMIA |
10 |
0.0014 |
| 206 |
CRANIAL NERVE DISORDER |
1 |
0.0014 |
| 207 |
FUSARIUM INFECTION |
1 |
0.0014 |
| 208 |
BRONCHOPULMONARY ASPERGILLOSIS |
11 |
0.0014 |
| 209 |
TONGUE PARALYSIS |
1 |
0.0014 |
| 210 |
INVESTIGATION ABNORMAL |
2 |
0.0014 |
| 211 |
VASOGENIC CEREBRAL OEDEMA |
1 |
0.0014 |
| 212 |
COMA HEPATIC |
1 |
0.0013 |
| 213 |
LARGE INTESTINAL OBSTRUCTION |
3 |
0.0013 |
| 214 |
ARTERIAL INJURY |
1 |
0.0013 |
| 215 |
MARASMUS |
2 |
0.0013 |
| 216 |
CYTOMEGALOVIRUS COLITIS |
3 |
0.0013 |
| 217 |
RESPIRATORY TRACT INFECTION VIRAL |
3 |
0.0013 |
| 218 |
ACUTE MYELOID LEUKAEMIA |
20 |
0.0013 |
| 219 |
SUPERINFECTION BACTERIAL |
1 |
0.0013 |
| 220 |
HEPATIC CYTOLYSIS |
16 |
0.0013 |
| 221 |
PELVIC MASS |
1 |
0.0012 |
| 222 |
ENTEROCOCCAL SEPSIS |
1 |
0.0012 |
| 223 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
0.0012 |
| 224 |
SEBORRHOEIC DERMATITIS |
2 |
0.0012 |
| 225 |
CAMPYLOBACTER INFECTION |
1 |
0.0012 |
| 226 |
PERIPHERAL SENSORY NEUROPATHY |
7 |
0.0012 |
| 227 |
PYLORIC STENOSIS |
1 |
0.0012 |
| 228 |
DISSEMINATED TUBERCULOSIS |
3 |
0.0012 |
| 229 |
POLYNEUROPATHY |
14 |
0.0012 |
| 230 |
HYPOALBUMINAEMIA |
9 |
0.0012 |
| 231 |
GASTROINTESTINAL NEOPLASM |
1 |
0.0012 |
| 232 |
TRANSFUSION REACTION |
1 |
0.0011 |
| 233 |
NEUTROPENIC SEPSIS |
8 |
0.0011 |
| 234 |
CANDIDA SEPSIS |
1 |
0.0011 |
| 235 |
MYELOSUPPRESSION |
40 |
0.0011 |
| 236 |
BLOOD MAGNESIUM INCREASED |
1 |
0.0011 |
| 237 |
OROPHARYNGEAL CANDIDIASIS |
1 |
0.0011 |
| 238 |
MUSCLE SWELLING |
1 |
0.0011 |
| 239 |
ENTEROCOLITIS INFECTIOUS |
1 |
0.0011 |
| 240 |
C-REACTIVE PROTEIN |
1 |
0.0011 |
| 241 |
HYDRONEPHROSIS |
8 |
0.0011 |
| 242 |
PNEUMONIA CRYPTOCOCCAL |
1 |
0.0011 |
| 243 |
KLEBSIELLA BACTERAEMIA |
1 |
0.0011 |
| 244 |
PYELOCALIECTASIS |
1 |
0.0010 |
| 245 |
ALANINE AMINOTRANSFERASE INCREASED |
64 |
0.0010 |
| 246 |
PROSTATE INFECTION |
1 |
0.0010 |
| 247 |
HYPOCOAGULABLE STATE |
1 |
0.0010 |
| 248 |
CYTOMEGALOVIRUS CHORIORETINITIS |
2 |
0.0010 |
| 249 |
HAEMOPHILUS INFECTION |
1 |
0.0010 |
| 250 |
MASTOIDITIS |
1 |
0.0010 |
| 251 |
SPUTUM RETENTION |
1 |
0.0010 |
| 252 |
CELL DEATH |
2 |
0.0010 |
| 253 |
LARGE INTESTINE PERFORATION |
7 |
0.0010 |
| 254 |
SEPTIC SHOCK |
43 |
0.0010 |
| 255 |
BREAST NEOPLASM |
1 |
0.0010 |
| 256 |
METASTASES TO SKIN |
1 |
0.0010 |
| 257 |
ASPARTATE AMINOTRANSFERASE INCREASED |
51 |
0.0010 |
| 258 |
SERUM FERRITIN INCREASED |
5 |
0.0009 |
| 259 |
HYPOPHOSPHATAEMIA |
7 |
0.0009 |
| 260 |
HAEMATOTOXICITY |
9 |
0.0009 |
| 261 |
TUMOUR NECROSIS |
1 |
0.0009 |
| 262 |
ENTEROCOCCAL BACTERAEMIA |
1 |
0.0009 |
| 263 |
PNEUMONIA VIRAL |
3 |
0.0009 |
| 264 |
ORCHITIS |
1 |
0.0009 |
| 265 |
HYPERPHOSPHATAEMIA |
2 |
0.0009 |
| 266 |
HEPATIC LESION |
4 |
0.0009 |
| 267 |
STREPTOCOCCAL BACTERAEMIA |
1 |
0.0009 |
| 268 |
ACARODERMATITIS |
1 |
0.0009 |
| 269 |
ACINETOBACTER INFECTION |
1 |
0.0009 |
| 270 |
INTESTINAL ISCHAEMIA |
5 |
0.0009 |
| 271 |
CYTOMEGALOVIRUS VIRAEMIA |
4 |
0.0009 |
| 272 |
VANISHING BILE DUCT SYNDROME |
1 |
0.0009 |
| 273 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
9 |
0.0009 |
| 274 |
ADENOCARCINOMA |
2 |
0.0009 |
| 275 |
SARCOMA |
1 |
0.0009 |
| 276 |
CENTRAL NERVOUS SYSTEM INFECTION |
1 |
0.0009 |
| 277 |
TEMPERATURE INTOLERANCE |
9 |
0.0009 |
| 278 |
NEUROLOGICAL DECOMPENSATION |
2 |
0.0009 |
| 279 |
DERMATITIS EXFOLIATIVE GENERALISED |
3 |
0.0009 |
| 280 |
THROMBOCYTOPENIA |
95 |
0.0008 |
| 281 |
STREPTOCOCCAL SEPSIS |
1 |
0.0008 |
| 282 |
SECOND PRIMARY MALIGNANCY |
7 |
0.0008 |
| 283 |
PNEUMONIA INFLUENZAL |
1 |
0.0008 |
| 284 |
BONE LESION |
3 |
0.0008 |
| 285 |
BLEEDING TIME PROLONGED |
1 |
0.0008 |
| 286 |
CLOSTRIDIUM COLITIS |
1 |
0.0008 |
| 287 |
SECONDARY IMMUNODEFICIENCY |
1 |
0.0008 |
| 288 |
ENCEPHALITIS VIRAL |
1 |
0.0008 |
| 289 |
BLOOD IMMUNOGLOBULIN G DECREASED |
2 |
0.0008 |
| 290 |
LEUKOENCEPHALOPATHY |
3 |
0.0008 |
| 291 |
INTESTINAL PERFORATION |
9 |
0.0008 |
| 292 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
1 |
0.0008 |
| 293 |
LYMPHOCYTE COUNT DECREASED |
14 |
0.0008 |
| 294 |
INFECTION |
114 |
0.0008 |
| 295 |
NEOPLASM |
9 |
0.0008 |
| 296 |
CANCER PAIN |
2 |
0.0008 |
| 297 |
BLOOD BILIRUBIN INCREASED |
21 |
0.0008 |
| 298 |
NEOPLASM PROGRESSION |
27 |
0.0008 |
| 299 |
TRANSITIONAL CELL CARCINOMA |
1 |
0.0008 |
| 300 |
PNEUMONIA BACTERIAL |
7 |
0.0008 |
| 301 |
ENCEPHALITIS AUTOIMMUNE |
1 |
0.0008 |
| 302 |
CREATININE RENAL CLEARANCE DECREASED |
3 |
0.0007 |
| 303 |
ABDOMINAL MASS |
2 |
0.0007 |
| 304 |
LYMPHOCYTE PERCENTAGE DECREASED |
1 |
0.0007 |
| 305 |
NEUROMYELITIS OPTICA SPECTRUM DISORDER |
1 |
0.0007 |
| 306 |
HYPERCALCAEMIA |
9 |
0.0007 |
| 307 |
COVID-19 |
126 |
0.0007 |
| 308 |
LYMPHOMA |
11 |
0.0007 |
| 309 |
INTESTINAL FISTULA |
1 |
0.0007 |
| 310 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
2 |
0.0007 |
| 311 |
SINUS TACHYCARDIA |
10 |
0.0007 |
| 312 |
LUNG NEOPLASM |
3 |
0.0007 |
| 313 |
TUMOUR HAEMORRHAGE |
2 |
0.0007 |
| 314 |
POST HERPETIC NEURALGIA |
1 |
0.0007 |
| 315 |
NOROVIRUS INFECTION |
1 |
0.0007 |
| 316 |
BLOOD URIC ACID INCREASED |
4 |
0.0007 |
| 317 |
PULMONARY SEPSIS |
1 |
0.0007 |
| 318 |
SUPERINFECTION |
1 |
0.0007 |
| 319 |
STEROID DIABETES |
1 |
0.0007 |
| 320 |
HEPATITIS B |
4 |
0.0007 |
| 321 |
LUMBAR VERTEBRAL FRACTURE |
3 |
0.0007 |
| 322 |
GENITAL HERPES |
1 |
0.0007 |
| 323 |
PNEUMONIA PSEUDOMONAL |
1 |
0.0007 |
| 324 |
NEOPLASM SKIN |
1 |
0.0006 |
| 325 |
PYREXIA |
221 |
0.0006 |
| 326 |
NEUTROPHIL COUNT DECREASED |
26 |
0.0006 |
| 327 |
FUNGAEMIA |
1 |
0.0006 |
| 328 |
HEPATITIS B REACTIVATION |
2 |
0.0006 |
| 329 |
CYSTITIS INTERSTITIAL |
1 |
0.0006 |
| 330 |
IMMUNE-MEDIATED MYOCARDITIS |
1 |
0.0006 |
| 331 |
BACTERIAL SEPSIS |
2 |
0.0006 |
| 332 |
VASOPLEGIA SYNDROME |
1 |
0.0006 |
| 333 |
SHOCK |
14 |
0.0006 |
| 334 |
IMMUNE SYSTEM DISORDER |
8 |
0.0006 |
| 335 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
5 |
0.0006 |
| 336 |
SYSTEMIC INFECTION |
1 |
0.0006 |
| 337 |
ANAEMIA |
115 |
0.0006 |
| 338 |
CYTOMEGALOVIRUS INFECTION |
10 |
0.0006 |
| 339 |
CARDIAC FAILURE ACUTE |
4 |
0.0006 |
| 340 |
MYOCARDIAL NECROSIS MARKER INCREASED |
1 |
0.0006 |
| 341 |
SKIN WOUND |
1 |
0.0006 |
| 342 |
TACHYPNOEA |
8 |
0.0006 |
| 343 |
PNEUMONITIS |
16 |
0.0006 |
| 344 |
RETINITIS |
1 |
0.0006 |
| 345 |
VASCULAR PSEUDOANEURYSM |
1 |
0.0006 |
| 346 |
NEUROTOXICITY |
10 |
0.0006 |
| 347 |
METASTASES TO LIVER |
10 |
0.0006 |
| 348 |
CYTOMEGALOVIRUS TEST POSITIVE |
1 |
0.0006 |
| 349 |
VOCAL CORD PARALYSIS |
1 |
0.0006 |
| 350 |
IMMUNE-MEDIATED LUNG DISEASE |
1 |
0.0005 |
| 351 |
DISORGANISED SPEECH |
1 |
0.0005 |
| 352 |
PUPILLARY REFLEX IMPAIRED |
1 |
0.0005 |
| 353 |
FUNGAL INFECTION |
18 |
0.0005 |
| 354 |
CARDIAC DYSFUNCTION |
2 |
0.0005 |
| 355 |
IMMUNODEFICIENCY |
8 |
0.0005 |
| 356 |
MALNUTRITION |
6 |
0.0005 |
| 357 |
SACROILIITIS |
1 |
0.0005 |
| 358 |
GRANULOCYTOPENIA |
3 |
0.0005 |
| 359 |
LYMPHADENOPATHY MEDIASTINAL |
1 |
0.0005 |
| 360 |
ENTEROCOLITIS |
3 |
0.0005 |
| 361 |
TRAUMATIC LUNG INJURY |
1 |
0.0005 |
| 362 |
PNEUMONIA CYTOMEGALOVIRAL |
1 |
0.0005 |
| 363 |
RHINOVIRUS INFECTION |
2 |
0.0005 |
| 364 |
THERAPY PARTIAL RESPONDER |
8 |
0.0005 |
| 365 |
BACTERAEMIA |
6 |
0.0005 |
| 366 |
LARGE INTESTINAL STENOSIS |
1 |
0.0005 |
| 367 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 368 |
C-REACTIVE PROTEIN INCREASED |
18 |
0.0005 |
| 369 |
IMMUNE-MEDIATED HEPATITIS |
1 |
0.0005 |
| 370 |
VENOUS THROMBOSIS LIMB |
1 |
0.0005 |
| 371 |
OLIGURIA |
3 |
0.0005 |
| 372 |
HYPERBILIRUBINAEMIA |
5 |
0.0005 |
| 373 |
VIRAL INFECTION |
16 |
0.0005 |
| 374 |
EPSTEIN-BARR VIRUS INFECTION |
3 |
0.0005 |
| 375 |
LEUKOPENIA |
24 |
0.0005 |
| 376 |
PLATELET COUNT DECREASED |
51 |
0.0005 |
| 377 |
ESCHERICHIA URINARY TRACT INFECTION |
2 |
0.0005 |
| 378 |
INCORRECT DRUG ADMINISTRATION RATE |
2 |
0.0005 |
| 379 |
ENTERITIS |
3 |
0.0005 |
| 380 |
CD4 LYMPHOCYTES DECREASED |
1 |
0.0005 |
| 381 |
LYMPHOCYTOSIS |
1 |
0.0005 |
| 382 |
METASTATIC NEOPLASM |
2 |
0.0005 |
| 383 |
HERPES SIMPLEX |
3 |
0.0005 |
| 384 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
4 |
0.0005 |
| 385 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
13 |
0.0005 |
| 386 |
SEPSIS |
51 |
0.0005 |
| 387 |
NOSOCOMIAL INFECTION |
1 |
0.0005 |
| 388 |
RESPIRATORY FAILURE |
33 |
0.0005 |
| 389 |
LYMPHADENOPATHY |
16 |
0.0005 |
| 390 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
1 |
0.0004 |
| 391 |
HEPATIC FUNCTION ABNORMAL |
16 |
0.0004 |
| 392 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 393 |
METASTASES TO BONE |
7 |
0.0004 |
| 394 |
LYMPHOPENIA |
6 |
0.0004 |
| 395 |
URINARY TRACT OBSTRUCTION |
1 |
0.0004 |
| 396 |
MUCOSAL INFLAMMATION |
11 |
0.0004 |
| 397 |
INTRA-ABDOMINAL HAEMORRHAGE |
1 |
0.0004 |
| 398 |
LACUNAR INFARCTION |
1 |
0.0004 |
| 399 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
7 |
0.0004 |
| 400 |
MYELODYSPLASTIC SYNDROME |
6 |
0.0004 |
| 401 |
ENTEROCOCCAL INFECTION |
2 |
0.0004 |
| 402 |
PANCYTOPENIA |
23 |
0.0004 |
| 403 |
BRONCHITIS CHRONIC |
1 |
0.0004 |
| 404 |
GLOMERULONEPHRITIS |
1 |
0.0004 |
| 405 |
WHITE BLOOD CELL COUNT DECREASED |
44 |
0.0004 |
| 406 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0004 |
| 407 |
HYPERVOLAEMIA |
2 |
0.0004 |
| 408 |
INFLAMMATORY MARKER INCREASED |
2 |
0.0004 |
| 409 |
KETOACIDOSIS |
3 |
0.0004 |
| 410 |
HYPERAMMONAEMIA |
2 |
0.0004 |
| 411 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
7 |
0.0004 |
| 412 |
DYSPHORIA |
2 |
0.0004 |
| 413 |
HYPERTHERMIA |
3 |
0.0004 |
| 414 |
ABDOMINAL INFECTION |
1 |
0.0004 |
| 415 |
URINARY RETENTION |
13 |
0.0004 |
| 416 |
BLOOD CHLORIDE DECREASED |
1 |
0.0004 |
| 417 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
1 |
0.0004 |
| 418 |
MUCORMYCOSIS |
1 |
0.0004 |
| 419 |
MALIGNANT NEOPLASM PROGRESSION |
39 |
0.0004 |
| 420 |
BLOOD LACTIC ACID INCREASED |
2 |
0.0004 |
| 421 |
RADICULOPATHY |
1 |
0.0004 |
| 422 |
THERAPY NON-RESPONDER |
17 |
0.0004 |
| 423 |
GASTROINTESTINAL STROMAL TUMOUR |
1 |
0.0004 |
| 424 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 425 |
HYPERLACTACIDAEMIA |
1 |
0.0004 |
| 426 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
1 |
0.0004 |
| 427 |
OFF LABEL USE |
325 |
0.0004 |
| 428 |
HYPOXIA |
13 |
0.0004 |
| 429 |
NECROSIS |
2 |
0.0004 |
| 430 |
LUNG CONSOLIDATION |
1 |
0.0004 |
| 431 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 432 |
CANDIDA INFECTION |
6 |
0.0004 |
| 433 |
NECK MASS |
1 |
0.0004 |
| 434 |
DEATH |
304 |
0.0004 |
| 435 |
INJECTION SITE SCAR |
1 |
0.0004 |
| 436 |
PSEUDOMONAS INFECTION |
3 |
0.0003 |
| 437 |
PHARYNGEAL DISORDER |
1 |
0.0003 |
| 438 |
LUNG CANCER METASTATIC |
1 |
0.0003 |
| 439 |
PLEURAL EFFUSION |
21 |
0.0003 |
| 440 |
ESCHERICHIA SEPSIS |
1 |
0.0003 |
| 441 |
METABOLIC DISORDER |
2 |
0.0003 |
| 442 |
LUNG INFILTRATION |
3 |
0.0003 |
| 443 |
PERITONITIS |
7 |
0.0003 |
| 444 |
PLEURISY |
2 |
0.0003 |
| 445 |
NO ADVERSE EVENT |
61 |
0.0003 |
| 446 |
THYROIDITIS |
1 |
0.0003 |
| 447 |
LUNG ADENOCARCINOMA |
1 |
0.0003 |
| 448 |
RECTAL CANCER |
1 |
0.0003 |
| 449 |
GLOMERULAR FILTRATION RATE DECREASED |
4 |
0.0003 |
| 450 |
UROSEPSIS |
3 |
0.0003 |
| 451 |
DEVICE RELATED INFECTION |
5 |
0.0003 |
| 452 |
AGRANULOCYTOSIS |
6 |
0.0003 |
| 453 |
SQUAMOUS CELL CARCINOMA |
3 |
0.0003 |
| 454 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 455 |
PNEUMONIA |
102 |
0.0003 |
| 456 |
LIVER ABSCESS |
1 |
0.0003 |
| 457 |
AUTOIMMUNE DISORDER |
3 |
0.0003 |
| 458 |
HYPOVENTILATION |
1 |
0.0003 |
| 459 |
ASPERGILLUS INFECTION |
2 |
0.0003 |
| 460 |
SARS-COV-2 TEST POSITIVE |
4 |
0.0003 |
| 461 |
NEPHRITIS |
1 |
0.0003 |
| 462 |
METASTASES TO SPINE |
1 |
0.0003 |
| 463 |
BRONCHIECTASIS |
2 |
0.0003 |
| 464 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 465 |
HEPATIC CYST |
1 |
0.0003 |
| 466 |
BODY TEMPERATURE INCREASED |
6 |
0.0003 |
| 467 |
SUDDEN CARDIAC DEATH |
1 |
0.0003 |
| 468 |
NEUTROPHIL COUNT INCREASED |
3 |
0.0003 |
| 469 |
ATRIAL FIBRILLATION |
28 |
0.0003 |
| 470 |
INFUSION RELATED REACTION |
19 |
0.0003 |
| 471 |
LOGORRHOEA |
1 |
0.0003 |
| 472 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 473 |
INTERCEPTED PRODUCT STORAGE ERROR |
1 |
0.0003 |
| 474 |
ABDOMINAL PAIN LOWER |
7 |
0.0003 |
| 475 |
BLOOD CREATININE INCREASED |
18 |
0.0003 |
| 476 |
MONOCYTE COUNT INCREASED |
1 |
0.0003 |
| 477 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 478 |
DRUG RESISTANCE |
7 |
0.0003 |
| 479 |
IMMUNE-MEDIATED ENTEROCOLITIS |
1 |
0.0003 |
| 480 |
AMYLASE INCREASED |
1 |
0.0003 |
| 481 |
BLOOD PRESSURE DECREASED |
18 |
0.0003 |
| 482 |
TRANSAMINASES INCREASED |
6 |
0.0003 |
| 483 |
RASH MACULO-PAPULAR |
6 |
0.0003 |
| 484 |
RESPIRATORY TRACT INFECTION |
7 |
0.0003 |
| 485 |
SKIN INFECTION |
3 |
0.0003 |
| 486 |
OXYGEN SATURATION DECREASED |
15 |
0.0003 |
| 487 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 488 |
HYPOCALCAEMIA |
5 |
0.0003 |
| 489 |
TROPONIN INCREASED |
2 |
0.0003 |
| 490 |
HERPES ZOSTER |
15 |
0.0003 |
| 491 |
HAEMOLYSIS |
2 |
0.0003 |
| 492 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
6 |
0.0003 |
| 493 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 494 |
SPLENOMEGALY |
3 |
0.0003 |
| 495 |
ORAL INFECTION |
1 |
0.0003 |
| 496 |
HAEMATOCRIT DECREASED |
5 |
0.0003 |
| 497 |
INFLAMMATION |
13 |
0.0003 |
| 498 |
RENAL CYST |
2 |
0.0003 |
| 499 |
BLOOD DISORDER |
2 |
0.0002 |
| 500 |
INTERSTITIAL LUNG DISEASE |
12 |
0.0002 |
| 501 |
PRODUCT ADMINISTRATION ERROR |
5 |
0.0002 |
| 502 |
SHOCK HAEMORRHAGIC |
2 |
0.0002 |
| 503 |
INTERCEPTED PRODUCT PREPARATION ERROR |
3 |
0.0002 |
| 504 |
HYPERURICAEMIA |
1 |
0.0002 |
| 505 |
EXTRAVASATION |
1 |
0.0002 |
| 506 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 507 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 508 |
BRAIN OEDEMA |
3 |
0.0002 |
| 509 |
BUNDLE BRANCH BLOCK LEFT |
1 |
0.0002 |
| 510 |
FEBRILE BONE MARROW APLASIA |
1 |
0.0002 |
| 511 |
FACIAL PARALYSIS |
2 |
0.0002 |
| 512 |
PULMONARY TUBERCULOSIS |
1 |
0.0002 |
| 513 |
PYELONEPHRITIS |
2 |
0.0002 |
| 514 |
FAECES DISCOLOURED |
5 |
0.0002 |
| 515 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 516 |
URINE OUTPUT DECREASED |
2 |
0.0002 |
| 517 |
DIVERTICULUM INTESTINAL |
1 |
0.0002 |
| 518 |
PULMONARY FUNCTION TEST DECREASED |
1 |
0.0002 |
| 519 |
BEDRIDDEN |
3 |
0.0002 |
| 520 |
DISORIENTATION |
9 |
0.0002 |
| 521 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 522 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
5 |
0.0002 |
| 523 |
LIVER DISORDER |
10 |
0.0002 |
| 524 |
NERVOUS SYSTEM DISORDER |
7 |
0.0002 |
| 525 |
CARDIAC FAILURE |
18 |
0.0002 |
| 526 |
GASTROINTESTINAL INFECTION |
2 |
0.0002 |
| 527 |
MENINGITIS ASEPTIC |
1 |
0.0002 |
| 528 |
IRON DEFICIENCY |
1 |
0.0002 |
| 529 |
NEUROPATHY PERIPHERAL |
21 |
0.0002 |
| 530 |
HYPOTENSION |
44 |
0.0002 |
| 531 |
MOVEMENT DISORDER |
7 |
0.0002 |
| 532 |
HYPOKALAEMIA |
10 |
0.0002 |
| 533 |
UPPER RESPIRATORY TRACT INFECTION |
10 |
0.0002 |
| 534 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 535 |
PERFORMANCE STATUS DECREASED |
1 |
0.0002 |
| 536 |
APPENDICITIS |
2 |
0.0002 |
| 537 |
ILL-DEFINED DISORDER |
13 |
0.0002 |
| 538 |
BLOOD TEST ABNORMAL |
3 |
0.0002 |
| 539 |
BLOOD SODIUM DECREASED |
4 |
0.0002 |
| 540 |
LEUKAEMIA |
2 |
0.0002 |
| 541 |
ACUTE KIDNEY INJURY |
32 |
0.0002 |
| 542 |
SUPRAVENTRICULAR TACHYCARDIA |
2 |
0.0002 |
| 543 |
HYPOVOLAEMIC SHOCK |
1 |
0.0002 |
| 544 |
NON-SMALL CELL LUNG CANCER |
1 |
0.0002 |
| 545 |
CHOLESTASIS |
4 |
0.0002 |
| 546 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 547 |
ACUTE MYOCARDIAL INFARCTION |
6 |
0.0002 |
| 548 |
CARDIOMYOPATHY |
3 |
0.0002 |
| 549 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 550 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
8 |
0.0002 |
| 551 |
HYPERNATRAEMIA |
1 |
0.0002 |
| 552 |
HAEMORRHAGE INTRACRANIAL |
3 |
0.0002 |
| 553 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 554 |
HYPOTHERMIA |
2 |
0.0002 |
| 555 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 556 |
HAEMATEMESIS |
5 |
0.0002 |
| 557 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 558 |
CHILLS |
23 |
0.0002 |
| 559 |
CACHEXIA |
1 |
0.0002 |
| 560 |
GASTROINTESTINAL HAEMORRHAGE |
16 |
0.0002 |
| 561 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 562 |
HEPATIC ENZYME INCREASED |
13 |
0.0002 |
| 563 |
CATATONIA |
1 |
0.0002 |
| 564 |
ANAL FISSURE |
1 |
0.0002 |
| 565 |
LIVER FUNCTION TEST INCREASED |
4 |
0.0002 |
| 566 |
ANAL ABSCESS |
1 |
0.0002 |
| 567 |
DECREASED ACTIVITY |
2 |
0.0002 |
| 568 |
DEEP VEIN THROMBOSIS |
12 |
0.0002 |
| 569 |
CLOSTRIDIUM DIFFICILE INFECTION |
4 |
0.0002 |
| 570 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 571 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 572 |
NEPHROPATHY TOXIC |
2 |
0.0002 |
| 573 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 574 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 575 |
MYOCARDIAL ISCHAEMIA |
2 |
0.0002 |
| 576 |
HAEMOGLOBIN DECREASED |
18 |
0.0002 |
| 577 |
HAEMATURIA |
6 |
0.0002 |
| 578 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 579 |
NEUROLOGICAL SYMPTOM |
1 |
0.0002 |
| 580 |
HYPERTONIA |
1 |
0.0002 |
| 581 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 582 |
PERICARDIAL EFFUSION |
4 |
0.0002 |
| 583 |
GENERAL PHYSICAL HEALTH DETERIORATION |
20 |
0.0002 |
| 584 |
ELECTROLYTE IMBALANCE |
2 |
0.0002 |
| 585 |
EYELID OEDEMA |
2 |
0.0002 |
| 586 |
SKIN WARM |
1 |
0.0002 |
| 587 |
VASCULITIS |
2 |
0.0002 |
| 588 |
INTENTIONAL PRODUCT USE ISSUE |
15 |
0.0002 |
| 589 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 590 |
DRUG ERUPTION |
3 |
0.0002 |
| 591 |
CHOLECYSTITIS |
2 |
0.0002 |
| 592 |
CEREBRAL HAEMORRHAGE |
6 |
0.0002 |
| 593 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 594 |
BLOOD POTASSIUM DECREASED |
5 |
0.0002 |
| 595 |
HEPATIC FAILURE |
5 |
0.0002 |
| 596 |
LEUKOCYTOSIS |
3 |
0.0002 |
| 597 |
APHASIA |
5 |
0.0002 |
| 598 |
LIVER INJURY |
4 |
0.0002 |
| 599 |
GENERALISED OEDEMA |
2 |
0.0002 |
| 600 |
CHOLANGITIS |
1 |
0.0002 |
| 601 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
4 |
0.0002 |
| 602 |
TOOTH EXTRACTION |
2 |
0.0002 |
| 603 |
PEMPHIGUS |
2 |
0.0002 |
| 604 |
PRODUCT USE ISSUE |
30 |
0.0002 |
| 605 |
COLITIS |
6 |
0.0002 |
| 606 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
1 |
0.0002 |
| 607 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
2 |
0.0002 |
| 608 |
RENAL IMPAIRMENT |
13 |
0.0002 |
| 609 |
LOWER RESPIRATORY TRACT INFECTION |
7 |
0.0002 |
| 610 |
ORAL CANDIDIASIS |
2 |
0.0002 |
| 611 |
DYSGRAPHIA |
1 |
0.0002 |
| 612 |
PANCREATITIS |
8 |
0.0002 |
| 613 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 614 |
SKIN MASS |
1 |
0.0001 |
| 615 |
MENINGITIS |
1 |
0.0001 |
| 616 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 617 |
MALIGNANT MELANOMA |
2 |
0.0001 |
| 618 |
FEEDING DISORDER |
3 |
0.0001 |
| 619 |
UVEITIS |
2 |
0.0001 |
| 620 |
GENERAL PHYSICAL CONDITION ABNORMAL |
1 |
0.0001 |
| 621 |
ACUTE HEPATIC FAILURE |
2 |
0.0001 |
| 622 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
0.0001 |
| 623 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 624 |
PAPULE |
1 |
0.0001 |
| 625 |
BRONCHOSPASM |
2 |
0.0001 |
| 626 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 627 |
UNDERDOSE |
10 |
0.0001 |
| 628 |
ASCITES |
4 |
0.0001 |
| 629 |
HEPATOTOXICITY |
3 |
0.0001 |
| 630 |
RENAL INJURY |
4 |
0.0001 |
| 631 |
INFLUENZA |
15 |
0.0001 |
| 632 |
PULMONARY MASS |
2 |
0.0001 |
| 633 |
HEPATOCELLULAR CARCINOMA |
1 |
0.0001 |
| 634 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 635 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
1 |
0.0001 |
| 636 |
EJECTION FRACTION DECREASED |
2 |
0.0001 |
| 637 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 638 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
9 |
0.0001 |
| 639 |
PULMONARY EMBOLISM |
12 |
0.0001 |
| 640 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 641 |
ULCER |
2 |
0.0001 |
| 642 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 643 |
BACK PAIN |
29 |
0.0001 |
| 644 |
HYPERHIDROSIS |
16 |
0.0001 |
| 645 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 646 |
LUNG DISORDER |
6 |
0.0001 |
| 647 |
ABNORMAL FAECES |
1 |
0.0001 |
| 648 |
HICCUPS |
1 |
0.0001 |
| 649 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 650 |
STAPHYLOCOCCAL INFECTION |
4 |
0.0001 |
| 651 |
CARDIAC ARREST |
10 |
0.0001 |
| 652 |
VENTRICULAR TACHYCARDIA |
2 |
0.0001 |
| 653 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 654 |
COAGULOPATHY |
2 |
0.0001 |
| 655 |
FACE OEDEMA |
2 |
0.0001 |
| 656 |
HEMIPARESIS |
2 |
0.0001 |
| 657 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 658 |
ANURIA |
1 |
0.0001 |
| 659 |
MYOPATHY |
1 |
0.0001 |
| 660 |
DEAFNESS |
3 |
0.0001 |
| 661 |
EOSINOPHILIA |
2 |
0.0001 |
| 662 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 663 |
GROIN PAIN |
1 |
0.0001 |
| 664 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 665 |
PURPURA |
1 |
0.0001 |
| 666 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 667 |
GASTROINTESTINAL DISORDER |
10 |
0.0001 |
| 668 |
URINARY TRACT INFECTION |
19 |
0.0001 |
| 669 |
CONFUSIONAL STATE |
18 |
0.0001 |
| 670 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 671 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 672 |
ARRHYTHMIA |
5 |
0.0001 |
| 673 |
RENAL FAILURE |
14 |
0.0001 |
| 674 |
GASTRIC ULCER |
2 |
0.0001 |
| 675 |
PRODUCTIVE COUGH |
5 |
0.0001 |
| 676 |
PULMONARY FIBROSIS |
2 |
0.0001 |
| 677 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 678 |
LIVER FUNCTION TEST ABNORMAL |
3 |
0.0001 |
| 679 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 680 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 681 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 682 |
PSYCHOTIC DISORDER |
3 |
0.0001 |
| 683 |
HOSPICE CARE |
1 |
0.0001 |
| 684 |
RESPIRATORY DISORDER |
3 |
0.0001 |
| 685 |
HYPOTONIA |
1 |
0.0001 |
| 686 |
EMPHYSEMA |
1 |
0.0001 |
| 687 |
PERITONITIS BACTERIAL |
1 |
0.0001 |
| 688 |
ABDOMINAL PAIN |
23 |
0.0001 |
| 689 |
EYELID PTOSIS |
1 |
0.0001 |
| 690 |
PRODUCT PREPARATION ERROR |
2 |
0.0001 |
| 691 |
SPEECH DISORDER |
5 |
0.0001 |
| 692 |
SUDDEN DEATH |
1 |
0.0001 |
| 693 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 694 |
EATING DISORDER |
2 |
0.0001 |
| 695 |
OVERDOSE |
20 |
0.0001 |
| 696 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 697 |
CHOLELITHIASIS |
3 |
0.0001 |
| 698 |
PRODUCT STORAGE ERROR |
8 |
0.0001 |
| 699 |
WOUND INFECTION |
1 |
0.0001 |
| 700 |
MELAENA |
2 |
0.0001 |
| 701 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 702 |
OEDEMA PERIPHERAL |
11 |
0.0001 |
| 703 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 704 |
STEVENS-JOHNSON SYNDROME |
2 |
0.0001 |
| 705 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 706 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 707 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 708 |
EYE INFECTION |
1 |
0.0001 |
| 709 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 710 |
REBOUND EFFECT |
1 |
0.0001 |
| 711 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 712 |
MUSCULAR WEAKNESS |
10 |
0.0001 |
| 713 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 714 |
DELIRIUM |
3 |
0.0001 |
| 715 |
HYPERKALAEMIA |
3 |
0.0001 |
| 716 |
DISEASE RECURRENCE |
4 |
0.0001 |
| 717 |
DRUG INTOLERANCE |
8 |
0.0001 |
| 718 |
THERAPEUTIC RESPONSE DECREASED |
5 |
0.0001 |
| 719 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 720 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 721 |
DECREASED APPETITE |
19 |
0.0001 |
| 722 |
HEART RATE INCREASED |
8 |
0.0001 |
| 723 |
ASTHENIA |
30 |
0.0001 |
| 724 |
INTESTINAL OBSTRUCTION |
3 |
0.0001 |
| 725 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 726 |
TACHYCARDIA |
7 |
0.0001 |
| 727 |
CARDIOVASCULAR DISORDER |
2 |
0.0001 |
| 728 |
COUGH |
22 |
0.0001 |
| 729 |
WHITE BLOOD CELL COUNT INCREASED |
3 |
0.0001 |
| 730 |
MYDRIASIS |
1 |
0.0001 |
| 731 |
DIPLOPIA |
2 |
0.0001 |
| 732 |
PRODUCT USE IN UNAPPROVED INDICATION |
19 |
0.0001 |
| 733 |
MUSCULOSKELETAL PAIN |
4 |
0.0001 |
| 734 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 735 |
INFLUENZA LIKE ILLNESS |
6 |
0.0001 |
| 736 |
DRUG INEFFECTIVE |
96 |
0.0001 |
| 737 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 738 |
HAEMATOCHEZIA |
4 |
0.0001 |
| 739 |
FEELING COLD |
2 |
0.0001 |
| 740 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 741 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 742 |
APHONIA |
1 |
0.0001 |
| 743 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 744 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 745 |
HYPONATRAEMIA |
4 |
0.0001 |
| 746 |
PARALYSIS |
1 |
0.0001 |
| 747 |
DYSSTASIA |
2 |
0.0001 |
| 748 |
SINUSITIS |
7 |
0.0001 |
| 749 |
ERYTHEMA |
14 |
0.0001 |
| 750 |
VOMITING |
32 |
0.0001 |
| 751 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 752 |
BRONCHITIS |
5 |
0.0001 |
| 753 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 754 |
OESOPHAGEAL CARCINOMA |
2 |
0.0001 |
| 755 |
RASH |
29 |
0.0001 |
| 756 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 757 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
0.0001 |
| 758 |
EPILEPSY |
2 |
0.0001 |
| 759 |
NEPHROLITHIASIS |
3 |
0.0001 |
| 760 |
SWELLING |
6 |
0.0001 |
| 761 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 762 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 763 |
DIARRHOEA |
41 |
0.0001 |
| 764 |
NIGHT SWEATS |
2 |
0.0001 |
| 765 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 766 |
SEIZURE |
7 |
0.0001 |
| 767 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 768 |
CELLULITIS |
3 |
0.0001 |
| 769 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 770 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 771 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 772 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 773 |
GOUT |
1 |
0.0001 |
| 774 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 775 |
SYNOVITIS |
1 |
0.0001 |
| 776 |
OSTEOMYELITIS |
1 |
0.0001 |
| 777 |
PELVIC PAIN |
1 |
0.0001 |
| 778 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 779 |
CARDIAC DISORDER |
5 |
0.0001 |
| 780 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 781 |
DYSARTHRIA |
2 |
0.0001 |
| 782 |
CONDITION AGGRAVATED |
16 |
0.0001 |
| 783 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 784 |
HYPERTENSION |
11 |
0.0001 |
| 785 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 786 |
EAR PAIN |
1 |
0.0001 |
| 787 |
HAEMORRHOIDS |
1 |
0.0001 |
| 788 |
ORAL HERPES |
1 |
0.0001 |
| 789 |
BONE PAIN |
3 |
0.0001 |
| 790 |
PARAESTHESIA |
8 |
0.0001 |
| 791 |
PAIN |
31 |
0.0001 |
| 792 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 793 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 794 |
TASTE DISORDER |
1 |
0.0000 |
| 795 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 796 |
DISCOMFORT |
3 |
0.0000 |
| 797 |
BLINDNESS |
2 |
0.0000 |
| 798 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 799 |
HAEMORRHAGE |
5 |
0.0000 |
| 800 |
MOUTH ULCERATION |
1 |
0.0000 |
| 801 |
SKIN CANCER |
1 |
0.0000 |
| 802 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 803 |
DYSPNOEA |
26 |
0.0000 |
| 804 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 805 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 806 |
ORAL PAIN |
1 |
0.0000 |
| 807 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 808 |
RENAL DISORDER |
2 |
0.0000 |
| 809 |
HEPATIC CANCER |
1 |
0.0000 |
| 810 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 811 |
PRESYNCOPE |
1 |
0.0000 |
| 812 |
NEURALGIA |
1 |
0.0000 |
| 813 |
AGITATION |
3 |
0.0000 |
| 814 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 815 |
EPISTAXIS |
3 |
0.0000 |
| 816 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 817 |
HEADACHE |
25 |
0.0000 |
| 818 |
FATIGUE |
31 |
0.0000 |
| 819 |
HEPATITIS |
1 |
0.0000 |
| 820 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 821 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 822 |
SKIN ULCER |
1 |
0.0000 |
| 823 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
| 824 |
OEDEMA |
2 |
0.0000 |
| 825 |
LIMB INJURY |
1 |
0.0000 |
| 826 |
NAUSEA |
29 |
0.0000 |
| 827 |
SKIN LESION |
1 |
0.0000 |
| 828 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 829 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 830 |
TREATMENT FAILURE |
3 |
0.0000 |
| 831 |
DIVERTICULITIS |
1 |
0.0000 |
| 832 |
HAEMOPTYSIS |
1 |
0.0000 |
| 833 |
SOMNOLENCE |
7 |
0.0000 |
| 834 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 835 |
PRURITUS |
13 |
0.0000 |
| 836 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 837 |
CATARACT |
2 |
0.0000 |
| 838 |
IRRITABILITY |
2 |
0.0000 |
| 839 |
NASOPHARYNGITIS |
6 |
0.0000 |
| 840 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 841 |
CYSTITIS |
1 |
0.0000 |
| 842 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 843 |
HIP FRACTURE |
1 |
0.0000 |
| 844 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 845 |
SYNCOPE |
3 |
0.0000 |
| 846 |
GAIT INABILITY |
1 |
0.0000 |
| 847 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 848 |
CEREBROVASCULAR ACCIDENT |
5 |
0.0000 |
| 849 |
MYALGIA |
5 |
0.0000 |
| 850 |
ABDOMINAL PAIN UPPER |
6 |
0.0000 |
| 851 |
DEVICE USE ERROR |
1 |
0.0000 |
| 852 |
RASH MACULAR |
1 |
0.0000 |
| 853 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 854 |
MUSCLE SPASMS |
5 |
0.0000 |
| 855 |
DYSURIA |
1 |
0.0000 |
| 856 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 857 |
DYSKINESIA |
1 |
0.0000 |
| 858 |
COMPLETED SUICIDE |
2 |
0.0000 |
| 859 |
MENTAL DISORDER |
1 |
0.0000 |
| 860 |
CONSTIPATION |
5 |
0.0000 |
| 861 |
MALAISE |
10 |
0.0000 |
| 862 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 863 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 864 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 865 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 866 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 867 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 868 |
FALL |
7 |
0.0000 |
| 869 |
COMA |
1 |
0.0000 |
| 870 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 871 |
DYSPEPSIA |
2 |
0.0000 |
| 872 |
HYPOAESTHESIA |
3 |
0.0000 |
| 873 |
AGGRESSION |
1 |
0.0000 |
| 874 |
FLUSHING |
2 |
0.0000 |
| 875 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 876 |
THERAPY CESSATION |
1 |
0.0000 |
| 877 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 878 |
TREMOR |
3 |
0.0000 |
| 879 |
MEDICATION ERROR |
1 |
0.0000 |
| 880 |
NECK PAIN |
1 |
0.0000 |
| 881 |
TOXICITY TO VARIOUS AGENTS |
3 |
0.0000 |
| 882 |
LETHARGY |
1 |
0.0000 |
| 883 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 884 |
WHEEZING |
1 |
0.0000 |
| 885 |
ARTHRALGIA |
7 |
0.0000 |
| 886 |
VERTIGO |
1 |
0.0000 |
| 887 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 888 |
SWELLING FACE |
1 |
0.0000 |
| 889 |
INSOMNIA |
4 |
0.0000 |
| 890 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 891 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 892 |
WEIGHT DECREASED |
4 |
0.0000 |
| 893 |
SLEEP DISORDER |
1 |
0.0000 |
| 894 |
DIZZINESS |
7 |
0.0000 |
| 895 |
MOBILITY DECREASED |
1 |
0.0000 |
| 896 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 897 |
DYSGEUSIA |
1 |
0.0000 |
| 898 |
HALLUCINATION |
1 |
0.0000 |
| 899 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 900 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 901 |
ARTHRITIS |
1 |
0.0000 |
| 902 |
FEELING ABNORMAL |
3 |
0.0000 |
| 903 |
THROMBOSIS |
1 |
0.0000 |
| 904 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 905 |
URTICARIA |
2 |
0.0000 |
| 906 |
BALANCE DISORDER |
1 |
0.0000 |
| 907 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 908 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 909 |
BREAST CANCER |
1 |
0.0000 |
| 910 |
DYSPHAGIA |
1 |
0.0000 |
| 911 |
CONTUSION |
1 |
0.0000 |
| 912 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 913 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 914 |
ILLNESS |
1 |
0.0000 |
| 915 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 916 |
WEIGHT INCREASED |
2 |
0.0000 |
| 917 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 918 |
PALPITATIONS |
1 |
0.0000 |
| 919 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 920 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 921 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 922 |
PSORIASIS |
1 |
0.0000 |
| 923 |
DEHYDRATION |
1 |
0.0000 |
| 924 |
VISION BLURRED |
1 |
0.0000 |
| 925 |
DRUG INTERACTION |
1 |
0.0000 |
| 926 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 927 |
CHEST PAIN |
1 |
0.0000 |
| 928 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 929 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 930 |
DEPRESSION |
1 |
0.0000 |
| 931 |
ANXIETY |
1 |
0.0000 |